MREO Mereo BioPharma Group plc

NASDAQ
$0.37

Mereo BioPharma Group plc (MREO) SEC Filings

Everything MREO has filed with the SEC, newest first. An 8-K shows what it was about where we have classified it — an earnings release and a change of chief executive are both 8-Ks, and the form number alone doesn't separate them.

25 filings
Date Form Filing
8-K Delisting
10-Q
10-Q
10-K
4
4
4
4
4
4
4
4
4
4
4
4
4
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K

Filings are sourced from EDGAR and open on the SEC's own site. Classification of 8-K events is ours and is not part of the filing.